×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
AstraZeneca concludes equity investment in Cellectis
Pharmaceutical Technology
AstraZeneca has concluded an equity investment in clinical-stage biotechnology company Cellectis following a deal signed in November 2023.
2 weeks ago
AstraZeneca Invests $140M in Cellectis, Secures 44% Stake in CAR-T Specialist
BioSpace
Cell and gene therapy company Cellectis announced Monday it has completed a $140 million investment from AstraZeneca that extends the...
2 weeks ago
AstraZeneca ups stake in Cellectis in latest cell therapy bet
Yahoo Finance
The British drugmaker, which has made genetic medicine a larger priority of late, added $140 million to a deal to develop up to 10 gene and...
2 weeks ago
Cellectis' open NC plant adds in-house capabilities BioProcess Insider
BioProcess International
Cellectis has opened its clinical and commercial manufacturing facility in Raleigh making it a one-stop-shop company, says firm.
2 months ago
CFOs depart Vir, Cellectis
BioCentury
Vir Biotechnology Inc. (NASDAQ:VIR) and Cellectis S.A. (Euronext:ALCLS; NASDAQ:CLLS) both announced CFO changes.
2 weeks ago
AstraZeneca to invest $245 mln in Cellectis to boost gene therapy prospects
Reuters
AstraZeneca said on Wednesday it would invest $245 million in French biotechnology company Cellectis in a deal aimed at speeding up the...
6 months ago
AstraZeneca takes 22% stake in Cellectis under 10-asset collab
Fierce Biotech
AstraZeneca takes 22% stake in Cellectis as part of collab for 10 cell and gene therapies ... Despite a rethink that saw Cellectis drop its...
6 months ago
Cellectis Announces Completion of the Additional Equity Investment by AstraZeneca
GlobeNewswire
Completion of the additional equity investment of $140M by AstraZeneca, as previously announced on November 1 and 15, 2023.
2 weeks ago
AstraZeneca Advances in Gene Therapy with Cellectis Stake - TipRanks.com
Tipranks
AstraZeneca (AZN) has released an update. AstraZeneca has finalized a significant equity investment in Cellectis, a biotech firm specializing in gene...
2 weeks ago
New AstraZeneca, Cellectis Alliance Spans Up to 10 Cell & Gene Therapies
MedCity News
New AstraZeneca, Cellectis Alliance Spans Up to 10 Cell & Gene Therapies. AstraZeneca starts the Cellectis partnership with $105 million in...
6 months ago